www.antimicrobe.org

[Start Page] [Microbes] [Antimicrobial Agents] [HIV Clinical Manual] [Feedback] [Logout]

Corynebacterium diphtheriae  (Diphtheria)

Read the Chapter

Sliding Table of Contents on the left of the screen

 

Tables and Figures

Table 1: In Vitro Suscetibility of Corynebacterium diphtheriae

 

Vignettes

Rosenberg CE.  Siting Epidemic Disease: 3 Centuries of American History. J Infect Dis 2008;197 (Suppl 1):S4-S6.

Schultz, M. Theobald Smith. Emerg Infect Dis. 2008. Dec; 14:1940-2.

 

Authors

Christine C. Chiou, M.D.

 

Smart Search

Guided PubMed Search on the Hit Page

We recommend this option for therapeutic recommendations

Corynebacterium diphtheriae

Select a topic and click onto Submit below:
EPIDEMIOLOGY MICROBIOLOGY CLINICAL MANIFESTATIONS  LAB  DIAGNOSIS PATHOGENESIS
SUSCEPTIBILITY
      In Vitro and In Vivo (Animal) Susceptibility | Synergistic Interactions in vitro
ANTIMICROBIAL THERAPY

     Antimicrobial Agent(s) of Choice | Alternative Therapy  | Combination Therapy | Dose |

     Route of Administration | Duration of Therapy | Endpoints for Monitoring Therapy

ADJUNCTIVE THERAPY
     Non-antimicrobial Therapy
PREVENTION
     General Preventive Measures | Hospital Infection Control Measures | Prophylaxis
VACCINES

 

 

www.antimicrobe.org

[Start Page] [Microbes] [Antimicrobial Agents] [HIV Clinical Manual] [Feedback] [Logout]